Current drug treatment strategies for atrial fibrillation and TASK-1 inhibition as an emerging novel therapy option
June 9, 2021 9:56 amKraft M, Büscher A, Wiedmann F, L’hoste Y, Haefeli WE, Frey N, Katus HA, Schmid C. Current drug treatment strategies for atrial fibrillation and TASK-1 inhibition as an emerging novel therapy option. Front Pharmacol 2021/12:638445. doi: 10.3389/fphar.2021.638445 .
Categorised in:
This post was written by sfb1425
